CXCL12 and neoplasm: CAFs were demonstrated in co-culture experiments to promote RCC growth and proliferation and that the expression of SDF-1 and its receptor CXCR4 affected tumor cell proliferation and chemoresistance through interactions in the TME, offering a potential pathway for therapeutic intervention [45,46].